Bioqual Pre-Tax Profit Margin 2010-2024 | BIOQ

Bioqual pre-tax profit margin from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Bioqual Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-11-30 $0.05B $-0.01B -10.00%
2024-08-31 $0.06B $-0.00B -3.64%
2024-05-31 $0.06B 0 0.00%
2024-02-29 $0.06B $0.00B 1.59%
2023-11-30 $0.06B $-0.00B -1.61%
2023-08-31 $0.06B 0 0.00%
2023-05-31 $0.06B $0.00B 1.59%
2023-02-28 $0.07B $0.00B 6.15%
2022-11-30 $0.07B $0.01B 10.29%
2022-08-31 $0.07B $0.01B 10.61%
2022-05-31 $0.07B $0.01B 10.77%
2022-02-28 $0.06B $0.00B 1.56%
2021-11-30 $0.06B $0.00B 1.67%
2021-08-31 $0.06B $0.00B 1.69%
2021-05-31 $0.06B $0.00B 1.69%
2021-02-28 $0.06B $0.01B 10.91%
2020-11-30 $0.05B $0.01B 11.11%
2020-08-31 $0.05B $0.01B 9.80%
2020-05-31 $0.05B $0.01B 10.87%
2020-02-29 $0.05B $0.02B 35.56%
2019-11-30 $0.04B $0.02B 37.21%
2019-08-31 $0.04B $0.02B 40.00%
2019-05-31 $0.04B $0.02B 60.00%
2019-02-28 $0.04B $0.02B 57.89%
2018-11-30 $0.04B $0.03B 80.56%
2018-08-31 $0.04B $0.04B 100.00%
2018-05-31 $0.04B $0.04B 100.00%
2018-02-28 $0.04B $0.04B 100.00%
2017-11-30 $0.04B $0.04B 100.00%
2017-08-31 $0.04B $0.04B 100.00%
2017-05-31 $0.04B $0.04B 100.00%
2017-02-28 $0.04B $0.04B 100.00%
2016-11-30 $0.04B $0.04B 100.00%
2016-08-31 $0.04B $0.04B 100.00%
2016-05-31 $0.03B $0.03B 100.00%
2016-02-29 $0.03B $0.03B 100.00%
2015-11-30 $0.03B $0.03B 100.00%
2015-08-31 $0.03B $0.03B 100.00%
2015-05-31 $0.03B $0.03B 100.00%
2015-02-28 $0.03B $0.03B 100.00%
2014-08-31 $0.02B $0.02B 100.00%
2014-05-31 $0.02B $0.02B 100.00%
2013-11-30 $0.02B $0.02B 100.00%
2013-08-31 $0.02B $0.02B 100.00%
2013-05-31 $0.02B $0.02B 100.00%
2012-05-31 $0.02B $0.02B 100.00%
2012-02-29 $0.02B $0.02B 100.00%
2011-11-30 $0.02B $0.02B 100.00%
2011-08-31 $0.02B $0.02B 100.00%
2011-05-31 $0.02B $0.02B 82.61%
2011-02-28 $0.04B $0.03B 88.57%
2010-11-30 $0.04B $0.03B 88.57%
2010-08-31 $0.04B $0.03B 88.57%
2010-05-31 $0.04B $0.03B 88.89%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.054B $0.059B
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.312B 0.00
Quest Diagnostics (DGX) United States $18.153B 18.23
DaVita (DVA) United States $14.110B 18.25
Encompass Health (EHC) United States $9.934B 22.26
Chemed (CHE) United States $8.335B 25.62
Elanco Animal Health (ELAN) United States $5.917B 14.08
Option Care Health (OPCH) United States $5.245B 24.85
RadNet (RDNT) United States $4.764B 105.51
LifeStance Health (LFST) United States $3.053B 0.00
Amedisys (AMED) United States $3.017B 21.47
Addus HomeCare (ADUS) United States $2.171B 25.48
Astrana Health (ASTH) United States $2.001B 27.37
U.S Physical Therapy (USPH) United States $1.324B 34.81
Aveanna Healthcare Holdings (AVAH) United States $0.935B 0.00
Pennant (PNTG) United States $0.935B 37.81
Atai Life Sciences (ATAI) Germany $0.356B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00